# Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea

> **NCT04091789** · PHASE2 · UNKNOWN · sponsor: **Pure Green** · enrollment: 30 (estimated)

## Conditions studied

- Dysmenorrhea
- Headache, Migraine
- Fatigue
- Nausea
- Mood Disturbance

## Interventions

- **DRUG:** Pure Femme Tablets

## Key facts

- **NCT ID:** NCT04091789
- **Lead sponsor:** Pure Green
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09
- **Primary completion:** 2020-03
- **Final completion:** 2020-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2019-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04091789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04091789, "Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04091789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*